Due: July 15, 2026
The objective of this RFI is to solicit feedback from industry, academia, and other stakeholders to assist BARDA in identifying and understanding the development maturity of Day-One influenza vaccine candidates and associated enabling technologies.
Responding to this opportunity requires membership in the Rapid Response Partnership Vehicle. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.